Daito Pharmaceutical (4577) · TargetRestated
Growth into a high-quality pharmaceutical company with a global presence
First written in FY2017. 1 of 2 entries say "Restated". Latest entry: FY2018.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Long-term global management founded on quality and physicians' trustA theme 2 companies write about · 0 as a headwind · 2 as a tailwind
1 other company's latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2018RestatedAnnual report
「Going forward, we aim to grow into a company that provides outstanding pharmaceuticals worldwide by further improving quality, taking on challenges in new pharmaceutical fields and new technologies.」
It reiterates the goal of growing into a company that provides pharmaceuticals worldwide through quality improvement and challenges in new fields and technologies. - FY2017First statedAnnual report
「Going forward, we aim to grow into a company that provides outstanding pharmaceuticals worldwide by further improving quality, taking on challenges in new pharmaceutical fields and new technologies.」
It records, for the first time, quality improvement, challenges in new fields and technologies, and the provision of pharmaceuticals worldwide as an integrated growth objective.